Adam Smith
Assistant Professor,
University of Toronto
Dr. Smith is a dual-boarded Clinical Cytogeneticist and Clinical Molecular Geneticist certified by the Canadian College of Medical Geneticists (CCMG). Dr. Smith is also a fellow of the American College of Genetics and Genomics (FACMG) and a Certified Laboratory Geneticist (erCLG) by the European Board of Medical Genetics.
Dr. Smith completed his Master's degree in 2000 in the Department of Laboratory Medicine and Pathobiology at the University of Toronto on the Pathomechanism of Costello syndrome. He completed his Ph.D. in the Institute of Medical Science at the University of Toronto unraveling the genetic and epigenetic mechanisms that control growth and cancer development at a locus on human chromosome 11 in the Beckwith-Wiedemann syndrome.
Dr. Smith has been an international leader in the development of Optical Genome Mapping technology. He led an International Consortium for Optical Genome Mapping and was the senior author of a Framework for Optical Genome Mapping clinical use in Hematologic Malignancies.
Dr. Smith completed his Master's degree in 2000 in the Department of Laboratory Medicine and Pathobiology at the University of Toronto on the Pathomechanism of Costello syndrome. He completed his Ph.D. in the Institute of Medical Science at the University of Toronto unraveling the genetic and epigenetic mechanisms that control growth and cancer development at a locus on human chromosome 11 in the Beckwith-Wiedemann syndrome.
Dr. Smith has been an international leader in the development of Optical Genome Mapping technology. He led an International Consortium for Optical Genome Mapping and was the senior author of a Framework for Optical Genome Mapping clinical use in Hematologic Malignancies.
)
)
){kind=logo}
){kind=logo}
){kind=logo}